EFS
PRTK

Essex Financial Services’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Essex Financial Services’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,800
Closed -$67K – 514
2021
Q3 		$67K Hold
13,800
– – 0.01% 462
2021
Q2 		$94K Buy
+13,800
New +$112K 0.01% 463

Other funds holding PRTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Financial Services's PRTK Position: Q4 2021 in Review

Essex Financial Services sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2021, closing a stake of 13,800 shares — an estimated $67K sold.

Essex Financial Services first reported a position in PRTK in Q2 2021 and held it in 2 quarters. The position peaked at $94K in Q2 2021. 103 funds tracked by Wall St. Rank hold PRTK as of Q4 2021.

  • Essex Financial Services reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Essex Financial Services sold 13,800 Paratek Pharmaceuticals, Inc. shares in Q4 2021, an estimated $67K.
  • Essex Financial Services first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
  • Essex Financial Services's Paratek Pharmaceuticals, Inc. position peaked at $94K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2021.

Based on Essex Financial Services's 13F filing for Q4 2021, filed 11 Feb 2022.